CCM
MED icon

Credo Capital Management’s Medifast MED Stock Holding History

Credo Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$14K Hold
539
– – 0.06% 153
2013
Q3 		$14K Sell
539
-144
-21% -$3.85K 0.02% 149
2013
Q2 		$18K Buy
+683
New +$17.9K 0.01% 110

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.28B AUM 23.15% 1-Year Est. Return
GGPE
Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credo Capital Management's MED Position: Q4 2013 in Review

Credo Capital Management held its Medifast (MED) position steady in Q4 2013 at 539 shares worth $14K. The position accounts for 0.06% of the portfolio, ranked #153.

Credo Capital Management first reported a position in MED in Q2 2013 and has held it in 3 quarters since. The position peaked at $18K in Q2 2013. 128 funds tracked by Wall St. Rank hold MED as of Q4 2013.

  • Credo Capital Management held 539 shares of Medifast worth $14K as of Q4 2013.
  • Credo Capital Management left its Medifast share count unchanged in Q4 2013.
  • Medifast made up 0.06% of Credo Capital Management's portfolio in Q4 2013, its #153 holding.
  • Credo Capital Management first reported a position in Medifast in Q2 2013 and has held it in 3 quarters since.
  • Credo Capital Management's Medifast position peaked at $18K in Q2 2013.
  • 128 funds tracked by Wall St. Rank held Medifast as of Q4 2013.

Based on Credo Capital Management's 13F filing for Q4 2013, filed 24 Jan 2014.